PT-141 · Mechanism of Action
Mechanism of Action
Quick answer
Published research describes PT-141 in terms of MC1R and related signaling. This is a generic summary of laboratory findings, not a statement about effects in people.
In published research, PT-141 (PT-141 (Bremelanotide)) is characterized as a research peptide that is studied primarily through its interaction with MC1R. The summary below describes the mechanisms reported in the scientific literature at a molecular level. It is educational reference information about laboratory study models, not a description of effects in humans.
Reported molecular targets
The research literature associates PT-141 with MC1R, MC3R, and MC4R (melanocortin receptor agonist). These are the interaction points most frequently referenced when the compound is discussed in mechanistic studies.
As with any research material, the precise pathways reported vary by model system, and findings are drawn from in-vitro and preclinical work rather than human data.
- Primary target
- MC1R
- Also referenced
- MC3R
- Also referenced
- MC4R (melanocortin receptor agonist)
Where this mechanism is studied
Mechanistic work involving PT-141 appears most often in the context of melanocortin-receptor research, neuroendocrine signaling models, and central-nervous-system studies. Investigators use these model systems to characterize the compound's behavior, not to establish any human application.
PT-141 is profiled here as laboratory reference information; Blueprint Labs stocks related research compounds rather than PT-141 itself.
Reading this responsibly
Mechanistic descriptions summarize what researchers have reported about molecular interactions. They are not evidence of safety or benefit in any organism, and they are not instructions for use. For research use only. Not for human consumption, diagnostic, or therapeutic use.
Questions, answered
What is the reported mechanism of PT-141?
Published research describes PT-141 in terms of MC1R and related signaling. This is a generic summary of laboratory findings, not a statement about effects in people.
Does this describe what PT-141 does in humans?
No. Everything here summarizes in-vitro and preclinical research models. For research use only. Not for human consumption, diagnostic, or therapeutic use.
Is PT-141 a small molecule or a peptide?
PT-141 is classified as a research peptide (molecular weight 1025.18 g/mol).